Progesterone vaginal - Duramed PharmaceuticalsAlternative Names: DR-2011
Latest Information Update: 12 Oct 2010
At a glance
- Originator Duramed Pharmaceuticals Inc
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 15 Mar 2016 Biomarkers information updated